Marie‐Hélène Mayrand

Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer

Marie‐Hélène Mayrand, Eliane Duarte‐Franco, Isabel Rodrigues et al. · New England Journal of Medicine · 2007 · 1.1K citations

Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis

Nicolas Van de Velde, Marie‐Claude Boily, Mélanie Drolet et al. · JNCI Journal of the National Cancer Institute · 2012 · 139 citations

Group-Based vs Individual Pelvic Floor Muscle Training to Treat Urinary Incontinence in Older Women

Chantale Dumoulin, Mélanie Morin, Coraline Danieli et al. · JAMA Internal Medicine · 2020 · 116 citations · Full text

Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm

Joseph E. Tota, J. Bentley, Jennifer Blake et al. · Preventive Medicine · 2017 · 113 citations

Molecular Hpv Testing, Cervical Cancer Management, Cervical Cancer Screening +15

Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: Design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST)

Marie‐Hélène Mayrand, Eliane Duarte‐Franco, François Coutlée et al. · International Journal of Cancer · 2006 · 112 citations · Full text

Diagnosis, Gynecology, Pathology +23